Trial Profile
A Single Arm Retrospective Observational Study Assessing the Efficacy of Elbasvir-Grazoprevir/Sofosbuvir and Ribavirin in Direct Acting Antiviral Therapy Failures in Pre and Post Liver Transplant Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 May 2018 New trial record
- 14 Apr 2018 Results presented at The International Liver Congress 2018.